What We Do
March 1, 2019
We attended the 15th Annual Biomarkers in Heart Failure and ACS meeting in La Jolla, CA.
February 26-28, 2019
Sapere Bio presented a poster with new data demonstrating AKI-Sapere can stratify patients by risk AKI before either CABG or cath/PCI.
February 13, 2019
"Life science startup Sapere Bio uses biomarkers to gauge patient health"
January 1, 2019
Sapere derives from the Latin meaning "to know."
November 30, 2018
Natalia Mitin (HealthSpan Dx CEO), Hyman Muss, Andrew Smitherman, and Kirsten Nyrop (UNC clinicians) presented on p16 biomarker applications in oncology. More info
Sapere Bio received a multi-year SBIR (Small Business Innovation Research) grant from the NIH and National Institute on Aging.
September 23-34, 2018
Natalia Mitin, HealthSpan Dx CEO, presented "Bringing Biomarkers of Aging Into the Clinic."
October 1, 2018
HealthSpan Dx tripled office and lab space with a move to custom-designed suits in the innovative Frontier campus.
May 17, 2018
Natalia Mitin provided an overview of our work and history for RTP180, a seminar on entrepreneurship.